Xiuquan Ma
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 09, 2025
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors.Farzaneh Shojaee, Esmaeel Azadian, Min Xian Wong
|Feb 21, 2025
Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.Xue Yang, Xiuquan Ma, Tianyue Zhao
|Jun 19, 2023
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling.Michael J Roy, Minglyanna G Surudoi, Ashleigh Kropp
|Jan 24, 2023
The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.Xue Yang, Miguel I Cruz, Elizabeth V Nguyen
|Feb 22, 2022
Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.Jianmei Hou, Elizabeth V Nguyen, Minglyanna Surudoi
|Jan 19, 2019
Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformation.Xiuquan Ma, Luxi Zhang, Jiangning Song
Pageof 1
Frequent Collaborators
4 joint publications
Roger J Daly
2 joint publications
Kimberley C Clark
2 joint publications
Terry C C Lim Kam Sian
2 joint publications
Minglyanna Surudoi
2 joint publications
Michael J Roy
2 joint publications
Onisha Patel
2 joint publications
Isabelle S Lucet
2 joint publications
Xue Yang
2 joint publications
Lan K Nguyen
2 joint publications
Sung-Young Shin
